Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell line
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
0717-6287
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell line ; volume:52 ; number:1 ; day:21 ; month:3 ; year:2019 ; pages:1-13 ; date:12.2019
Biological research ; 52, Heft 1 (21.3.2019), 1-13, 12.2019
- Creator
-
Viscarra, Tamara
Buchegger, Kurt
Jofre, Ignacio
Riquelme, Ismael
Zanella, Louise
Abanto, Michel
Parker, Alyssa C.
Piccolo, Stephen R.
Roa, Juan Carlos
Ili, Carmen
Brebi, Priscilla
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40659-019-0220-0
- URN
-
urn:nbn:de:101:1-2019050118551317553048
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Viscarra, Tamara
- Buchegger, Kurt
- Jofre, Ignacio
- Riquelme, Ismael
- Zanella, Louise
- Abanto, Michel
- Parker, Alyssa C.
- Piccolo, Stephen R.
- Roa, Juan Carlos
- Ili, Carmen
- Brebi, Priscilla
- SpringerLink (Online service)
Other Objects (12)
AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin
CircRAD23B promotes proliferation and carboplatin resistance in ovarian cancer cell lines and organoids
Sequential azacitidine and carboplatin induces immune activation in platinum-resistant high-grade serous ovarian cancer cell lines and primes for checkpoint inhibitor immunotherapy
Comparative transcriptomic analysis of antimony resistant and susceptible Leishmania infantum lines
Carboplatin hypersensitivity in relapsed ovarian carcinoma: A therapeutic challenge
Does the addition of metformin to carboplatin treatment decreases ovarian reserve damage associated with carboplatin usage?
Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models
Single-cell transcriptomic atlas of goat ovarian aging
Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer
HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study
MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines
AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin
CircRAD23B promotes proliferation and carboplatin resistance in ovarian cancer cell lines and organoids
Sequential azacitidine and carboplatin induces immune activation in platinum-resistant high-grade serous ovarian cancer cell lines and primes for checkpoint inhibitor immunotherapy
Comparative transcriptomic analysis of antimony resistant and susceptible Leishmania infantum lines
Carboplatin hypersensitivity in relapsed ovarian carcinoma: A therapeutic challenge
Does the addition of metformin to carboplatin treatment decreases ovarian reserve damage associated with carboplatin usage?
Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models
Single-cell transcriptomic atlas of goat ovarian aging
Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer
HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study
MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines
AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin
CircRAD23B promotes proliferation and carboplatin resistance in ovarian cancer cell lines and organoids
Sequential azacitidine and carboplatin induces immune activation in platinum-resistant high-grade serous ovarian cancer cell lines and primes for checkpoint inhibitor immunotherapy
Comparative transcriptomic analysis of antimony resistant and susceptible Leishmania infantum lines
Carboplatin hypersensitivity in relapsed ovarian carcinoma: A therapeutic challenge
Does the addition of metformin to carboplatin treatment decreases ovarian reserve damage associated with carboplatin usage?
Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models
Single-cell transcriptomic atlas of goat ovarian aging
Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer
HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study